How many people with employer-sponsored insurance use the drugs slated for Medicare price negotiations

A new analysis by KFF shows that out of the 167 million people with employer-sponsored insurance in 2022, 3.4 million used at least one of the 10 drugs selected for Medicare Part D price negotiations. The research is accessible on the Peterson-KFF Health System Tracker website.